Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain

Clinical Drug Investigation
Roberto LabiancaDiego Fornasari

Abstract

Chronic pain is a debilitating condition that is associated with many common diseases; this places a major burden on the healthcare system. There are currently numerous analgesic agents available for the treatment of chronic pain. In general, the oral non-opioid analgesic, paracetamol, is recommended for the initial treatment of mild to moderate pain. Therapeutic doses of paracetamol do not appear to result in hepatotoxicity, although overdose may lead to acute liver failure. Current data suggest that paracetamol has acceptable gastrointestinal tolerability. Another class of non-opioid analgesic with confirmed efficacy for the treatment of chronic mild to moderate pain are non-steroidal anti-inflammatory drugs (NSAIDs), although this efficacy is offset by the potential of adverse gastrointestinal events. In particular, non-selective NSAIDs, also known as cyclooxygenase (COX) inhibitors, carry an increased risk of serious upper gastrointestinal complications, including ulcers, perforation and bleeding. The introduction of COX-2 inhibitors provided a NSAID-based option with improved gastrointestinal safety, but increased risk of cardiovascular effects. Opioids are powerful analgesic agents used to treat moderate to severe chronic...Continue Reading

References

Feb 1, 1989·British Journal of Clinical Pharmacology·G ParrC J Bulpitt
Jul 1, 1995·Journal of Pain and Symptom Management·N D de StoutzM Suarez-Almazor
Apr 1, 1997·Alimentary Pharmacology & Therapeutics·A L BlowerK D Bardhan
Sep 16, 1998·Journal of Pain and Symptom Management·Z ZyliczM Krajnik
Jan 8, 1995·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·R G Large, S A Schug
Jun 17, 1999·The New England Journal of Medicine·M M WolfeG Singh
Mar 29, 2001·American Journal of Nephrology·D C BraterB J Gertz
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N ChernyUNKNOWN Expert Working Group of the European Association of Palliative Care Network
Mar 20, 2002·European Journal of Pain : EJP·E CatalàJ L Segú
Mar 23, 2002·The American Journal of Cardiology·Claire Bombardier
Apr 4, 2002·Alimentary Pharmacology & Therapeutics·J L GoldsteinG S Geis
Apr 17, 2002·Clinical Rheumatology·W A Katz
Aug 2, 2003·Clinical Pharmacology and Therapeutics·M Soledad CepedaBrian L Strom
Aug 26, 2003·European Journal of Pain : EJP·Eija KalsoMichael Zenz
Oct 31, 2003·Journal of Pain and Symptom Management·Eduardo BrueraAllen W Burton
Nov 14, 2003·The New England Journal of Medicine·Jane C Ballantyne, Jianren Mao
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Ewan McNicolUNKNOWN Americal Pain Society
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Michelle WheelerArthur G Lipman
Apr 28, 2004·Journal of Dental Research·B GötrickG Tobin
May 6, 2004·International Journal of Clinical Pharmacology and Therapeutics·K Raith, G Hochhaus
Jun 11, 2004·The New England Journal of Medicine·Christian C ApfelUNKNOWN IMPACT Investigators
Oct 9, 2004·Annals of the Rheumatic Diseases·W ZhangUNKNOWN EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Dec 8, 2004·Lancet·Peter JüniMatthias Egger
Aug 13, 2005·European Journal of Pain : EJP·Harald BreivikDerek Gallacher
Nov 29, 2005·European Journal of Pain : EJP·Anne M McDermottEllen M Dukes

❮ Previous
Next ❯

Citations

Jun 4, 2015·Expert Opinion on Investigational Drugs·José Miguel VelaCarmen Almansa
Sep 4, 2013·Current Medical Research and Opinion·Vittorio IornoVincenzo Moschini
Apr 17, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Eric Schoomaker, Chester Buckenmaier
Nov 28, 2015·Drug Discovery Today·Jonathan P RoiserAndrew D Blackwell
Apr 27, 2016·Indian Journal of Pharmacology·Veysel BaskınFatih İlkaya
Oct 4, 2015·Zeitschrift für Rheumatologie·J Jerosch
Jun 23, 2015·Seminars in Arthritis and Rheumatism·Yves HenrotinAlberto Migliore
Jul 11, 2013·Mediators of Inflammation·Beatrice Mihaela RaduPaolo Francesco Fabene
Jun 25, 2013·Neuropharmacology·Gabriela TrevisanJuliano Ferreira
Jan 28, 2014·Trends in Neurosciences·Christoforos Tsantoulas, Stephen B McMahon
Apr 4, 2015·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Benjamin G RoheCarlton R Cooper
Oct 2, 2012·Archives of Gerontology and Geriatrics·S M Halla-ahoK H Pitkälä
Jul 19, 2014·Drug and Alcohol Dependence·Jenna L McCauleySudie E Back
Dec 23, 2014·European Journal of Pharmacology·Ahmad A Altarifi, S Stevens Negus
Dec 12, 2012·BMC Urology·Matthias OllJörg Ellinger
Aug 25, 2016·Bioorganic & Medicinal Chemistry Letters·Steven L KuklishXiao-Peng Yu
Sep 15, 2016·Journal of Anaesthesiology, Clinical Pharmacology·Caitlyn Rose MossDmitri Bezinover
May 2, 2014·Journal of Analytical Toxicology·Kelley RameyCandis M Morello
Dec 28, 2016·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Henry B RandallKrista L Lentine
Jun 28, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Nasim Sadat PajohanfarBahareh Amin
Mar 8, 2018·British Journal of Clinical Pharmacology·Karima Hider-MlynarzPatrick Maison
Nov 28, 2017·Pain and Therapy·Diego Fornasari
Aug 30, 2017·Digestive Diseases and Sciences·Byron CryerMartin Wang
Oct 26, 2018·Pain Practice : the Official Journal of World Institute of Pain·Nicola AllegriElena Biagioli
Apr 21, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Julie H IshidaKirsten L Johansen
Oct 26, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·O CorliM Pizzuto
Apr 10, 2014·The Journal of Pharmacology and Experimental Therapeutics·Klaus LinzStefanie Frosch
Dec 17, 2014·The Journal of Pharmacology and Experimental Therapeutics·Anika L DzierlengaNathan J Cherrington
Feb 23, 2017·World Journal of Gastroenterology : WJG·Youssef AlhmadaMohamed Hassan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.